Built by the people who publish the evidence
oDIX8 is independent assurance for clinical AI. We assess clinical-AI tools and we do not build or sell them, so the verdict is yours to put in front of a buyer or a board. The team is deliberately small and senior, and independent: oDIX8 is not vendor-funded. The method is in the public record, not a brochure.
Odi founded oDIX8 and leads its method. He is a researcher at Martin-Luther-Universität Halle-Wittenberg, in the group of Professor Thomas Frese, President of WONCA Europe, and the author of a Springer monograph on implementation frameworks in healthcare and of the peer-reviewed and open-access research that underpins oDIX8, published as Florian Odi Stummer. He does not sell the tools he assesses.
“I don’t advise on AI in healthcare. I build it, deploy it, and publish the evidence.”
See the research →Sean is a London-based founder and investor who has built two companies, one pre-AI and one AI-native.
At oDIX8, Sean is your first point of contact: he leads business development and scopes engagements. To keep every assessment independent, the audit verdict itself is produced separately from any commercial relationship.
A senior advisory board
oDIX8 draws on a strategic advisory board spanning primary care, clinical AI, health policy and payor strategy. Depth where decisions are made, without the overhead of a large firm.
Offices. Halle (Saale), Germany · London, United Kingdom